---
name: Cellistic
slug: cellistic
site: cdmo
website_domain: cellistic.com
summary: Cellistic is an iPSC-focused CDMO offering integrated cell line development, process development, and GMP manufacturing for allogeneic cell therapy and regenerative medicine programs. The company operates a purpose-built, EMA-certified and FDA/PMDA-compliant manufacturing facility in Belgium. Headquartered in Mont-Saint-Guibert, Belgium.
tagline: iPSC-first CDMO for allogeneic cell therapy and regenerative medicine.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: BE
tier2_domain_verified: false
updated_at: 2026-07-05T07:01:34.379Z
services_count: 7
modalities_count: 1
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Cellistic

iPSC-first CDMO for allogeneic cell therapy and regenerative medicine.

Listed on cdmo.directory.

## Summary

Cellistic is an iPSC-focused CDMO offering integrated cell line development, process development, and GMP manufacturing for allogeneic cell therapy and regenerative medicine programs. The company operates a purpose-built, EMA-certified and FDA/PMDA-compliant manufacturing facility in Belgium. Headquartered in Mont-Saint-Guibert, Belgium.

## At a glance

- HQ country: BE

## Services

- Cell-Line Development
- Process Development
- CMC Analytical Development
- Allogeneic Cell Therapy Manufacturing
- Cell Therapy Manufacturing
- Quality Control Testing
- Technology Transfer

## Modalities

- Cell Therapy

## Locations

- Headquarters, Mont-Saint-Guibert, Belgium

## Certifications

- EMA; Identifier: EMA-certified iPSC cell therapy GMP manufacturing facility; Source: https://cellistic.com/
- FDA; Identifier: FDA-compliant; Source: https://cellistic.com/
- PMDA; Identifier: PMDA-compliant; Source: https://cellistic.com/

## Long description

## Overview

Cellistic is a specialized CDMO dedicated exclusively to iPSC-derived cell therapy and regenerative medicine. The company provides integrated support across the full development and manufacturing lifecycle, from cell line development through GMP manufacturing, process development, analytical development, quality control testing, and product release.

## Core Capabilities

**Technology Platforms:**
- **Pulse™ Cell Line Development Platform** — powered by proprietary STAR-CRISPR™ gene editing and Allo Chassis™ edited cell lines
- **Cellistic Echo™ Platform** — designed for scalable GMP manufacturing

**Service Scope:**
- iPSC cell line development and differentiation process establishment
- Process development and optimization
- Analytical method development and characterization
- GMP manufacturing at scale
- Quality control and release testing
- Technology transfer support

## Therapeutic Focus

Cellistic supports a broad range of immune and regenerative cell therapy applications, with particular expertise in:
- Allogeneic cell therapy development (moving beyond autologous or donor-derived approaches)
- iPSC-derived immune cell therapies
- Regenerative medicine programs

## Regulatory & Infrastructure

Headquartered in Mont-Saint-Guibert, Belgium, Cellistic operates a purpose-built, single-location facility that is:
- EMA-certified for iPSC cell therapy GMP manufacturing
- FDA-compliant
- PMDA-compliant

The integrated facility houses all development and manufacturing capabilities, enabling close client collaboration and alignment on shared manufacturing and commercialization goals.

_Profile last updated: 2026-07-05T07:01:34.379Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.